AY
Asha Yashwant Lanjewar
About Asha Yashwant Lanjewar
Data last updated:
Asha Yashwant Lanjewar is a Director at Puremed Pharma Private Limited (since 2016). The companies operate in Chemicals and Healthcare. Puremed Pharma Private Limited reported revenue of ₹13.3 Lakh (FY 2022). Earlier, Asha Yashwant Lanjewar was a Director at Cmh Bhandara Private Limited (2018–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jan 2016 | 2016 | ₹13.3 Lakh (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Feb 2018 | 2016 | ₹5.91 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Asha Yashwant Lanjewar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Narayan Jaydev Balpande | 07415704 | Puremed Pharma Private Limited | Director |
| Yashwant Gopalrao Lanjewar | 08041480 | Puremed Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Asha Yashwant Lanjewar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asha Yashwant Lanjewar
Asha Yashwant Lanjewar currently holds 1 directorship: Puremed Pharma Private Limited (Director, since 25 Jan 2016, revenue ₹13.3 Lakh (FY 2022)).
Asha Yashwant Lanjewar was first appointed on 25 Jan 2016 as Director at Puremed Pharma Private Limited. The most recent appointment on record is 10 Feb 2018 at Cmh Bhandara Private Limited.
Asha Yashwant Lanjewar held 1 earlier board appointment: Cmh Bhandara Private Limited (Director, 10 Feb 2018 to 28 May 2022).
The current boards of Asha Yashwant Lanjewar's companies include Narayan Jaydev Balpande (Puremed Pharma Private Limited), Yashwant Gopalrao Lanjewar (Puremed Pharma Private Limited).